Skip to main content
. 2006 Jul 17;63(12):828–835. doi: 10.1136/oem.2006.025213

Table 2 Prevalences of the 11 outcomes.

Study Prevalence within each study (%)
Standard deviation of area‐level prevalences within study (%)
Wheeze Asthma Bronchitis Phlegm Nocturnal cough Morning cough Sensitivity to inhaled allergens Hay fever Itchy rash Woken by wheeze Allergy to pets
Russia 13.40 1.88 14.72 7.15 11.35 6.44 1.21 4.36
2.6 1.1 3.7 1.7 2.7 2.4 1.0 1.2
Austria 13.55 8.59 10.42 5.30 12.78 5.24 8.17 5.81
2.1 3.5 2.1 1.4 2.5 2.1 2.1 1.6
Switzerland 10.37 8.98 18.25 21.54 11.90 13.73 10.15 13.29 4.64 4.56
2.1 2.2 7.8 9.8 4.1 2.1 2.5 2.5 1.3 1.2
Netherlands 9.54 8.14 7.92 9.54 21.58 15.22 7.19 22.26 4.93 9.30
3.6 4.1 3.7 4.1 6.5 5.7 3.2 5.3 2.4 4.1
Italy 6.72 9.00 12.43 5.53 15.73 10.92 7.81 14.16 1.82 1.82
1.2 2.5 4.4 1.6 2.5 2.2 2.3 2.8 1.0 1.1

Gaps occur where outcomes were not measured by all studies.